Edition:
United States

T2 Biosystems Inc (TTOO.OQ)

TTOO.OQ on NASDAQ Stock Exchange Global Market

7.00USD
10:40am EDT
Change (% chg)

$-0.01 (-0.14%)
Prev Close
$7.01
Open
$6.99
Day's High
$7.07
Day's Low
$6.95
Volume
10,902
Avg. Vol
173,328
52-wk High
$9.98
52-wk Low
$2.54

Select another date:

Thu, May 17 2018

BRIEF-T2 Biosystems Amends Oct. 10, 2014 Supply Agreement With SMC Ltd

* T2 BIOSYSTEMS SAYS ON MAY 16, CO & SMC LTD ENTERED INTO A THIRD AMENDMENT AMENDING CERTAIN SUPPLY AGREEMENT DATED AS OF OCT. 10, 2014 - SEC FILING

BRIEF-T2 Biosystems Reports Q1 Loss Per Share Of $0.36

* T2 BIOSYSTEMS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

BRIEF-T2 Biosystems Files For Non Timely 10-K

* T2 BIOSYSTEMS INC FILES FOR NON TIMELY 10-K - SEC FILING‍​ Source text - http://bit.ly/2ppkjtC Further company coverage:

BRIEF-T2 Biosystems Q4 Revenue Rose 55 Percent To $1.7 Million

* T2 BIOSYSTEMS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND BUSINESS UPDATE

BRIEF-T2 Biosystems Awarded Up To $2 Million By Carb-X To Support Development Of New Tests On The T2Dx Instrument For Drug-Resistant Bacteria

* T2 BIOSYSTEMS AWARDED UP TO $2 MILLION BY CARB-X TO SUPPORT DEVELOPMENT OF NEW TESTS ON THE T2DX INSTRUMENT FOR DRUG-RESISTANT BACTERIA Source text for Eikon: Further company coverage:

BRIEF-T2 Biosystems Says John Sprague Has Been Named CFO

* T2 BIOSYSTEMS INC - JOHN SPRAGUE HAS BEEN NAMED CHIEF FINANCIAL OFFICER Source text for Eikon: Further company coverage:

BRIEF-T2 Biosystems CFO Darlene Deptula-Hicks Resigns

* T2 BIOSYSTEMS- ON JAN 30, DARLENE DEPTULA-HICKS NOTIFIED CO OF HER RESIGNATION FROM POSITION AS CO'S CHIEF FINANCIAL OFFICER EFFECTIVE IMMEDIATELY

Select another date: